Steady-State Comparative Bioavailability Study in Patients Requiring Anti-Fungal Prophylaxis Comparing Twice a Day Dosing of Lozanoc (Mayne) Regardless of Food With Sporanox (Janssen) Under Fed Conditions

Trial Profile

Steady-State Comparative Bioavailability Study in Patients Requiring Anti-Fungal Prophylaxis Comparing Twice a Day Dosing of Lozanoc (Mayne) Regardless of Food With Sporanox (Janssen) Under Fed Conditions

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2016

At a glance

  • Drugs Itraconazole (Primary)
  • Indications Mycoses
  • Focus Pharmacokinetics
  • Sponsors Mayne Pharma Group
  • Most Recent Events

    • 21 Jul 2016 Last checked against ClinicalTrials.gov record.
    • 28 Apr 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
    • 28 Apr 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Nov 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top